Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DCS Innovative Diagnostik-Systeme
Hamburg, Hamburg, Germany
- Ownership
- Private
- Development stage
- Other
01
Overview
DCS develops and distributes specialized products for immunohistochemistry, including primary antibodies, highly sensitive detection systems, chromogens, reagents, and performance immunostaining systems, used widely in diagnostic and research pathology across Germany and internationally[1][2][3][7].
- Modalities
- AntibodyDiagnostic reagentImmunostaining system
- Industry
- Pathology
02
Partnerships
GenomeMe (exclusive antibody supplier)[8]BioGenex (exclusive antibody supplier)[8]DB Biotech (primary antibodies supplier)[8]
Beyond the preview
Go deeper on DCS Innovative Diagnostik-Systeme.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DCS Innovative Diagnostik-Systeme.